DOCSLIB.ORG

6.14 Alcohol Use Disorders and Alcoholic Liver Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
6.14 Alcohol Use Disorders and Alcoholic Liver Disease 6. Priority diseases and reasons for inclusion 6.14 Alcohol use disorders and alcoholic liver disease See Background Paper 6.14 (BP6_14Alcohol.pdf) Background The WHO estimates that alcohol is now the third highest risk factor for premature mortality, disability and loss of health worldwide.1 Between 2004 to 2006, alcohol use accounted for about 3.8% of all deaths (2.5 million) and about 4.5% (69.4 million) of Disability Adjusted Life Years (DALYS).2 Europe is the largest consumer of alcohol in the world and alcohol consumption in this region emerges as the third leading risk factor for disease and mortality.3 In European countries in 2004, an estimated one in seven male deaths (95 000) and one in 13 female deaths (over 25 000) in the 15 to 64 age group were due to alcohol-related causes.3 Alcohol is a causal factor in 60 types of diseases and injuries and a contributing factor in 200 others, and accounts for 20% to 50% of the prevalence of cirrhosis of the liver. Alcohol Use Disorders (AUD) account for a major part of neuropsychiatric disorders and contribute substantially to the global burden of disease. Alcohol dependence accounts for 71% of all alcohol-related deaths and for about 60% of social costs attributable to alcohol.4 The acute effects of alcohol consumption on the risk of both unintentional and intentional injuries also have a sizeable impact on the global burden of disease.2 Alcoholic liver disease (ALD) is the commonest cause of cirrhosis in the western world, and is currently one of the ten most common causes of death.5 Liver fibrosis caused by alcohol abuse and its end stage, cirrhosis, present enormous problems for health care worldwide. Over 60% of patients with cirrhosis of the liver and superimposed alcoholic hepatitis have a life expectancy of only four years. Overall, stopping drinking has been shown to improve the survival of patients with all stages of ALD. Developments since 2004 Despite the high global burden of alcohol-related diseases and injuries, alcohol use remains a low priority for public health policy. In North America, only an estimated 14.6% of people with a lifetime history of alcohol abuse or dependence have received treatment.6 In Europe, only an estimated 8% of people with alcohol dependence receive treatment.7 These low figures demonstrate that there are many barriers to treatment. Several policy options have been tested to reduce alcohol consumption, including: drunk driving reduction; education, communication, training and public awareness; alcohol market regulation; reduction of harm in drinking and surrounding environments; and interventions for individuals. 1 Priority Medicines for Europe and the World 2013 Update The currently approved pharmacotherapeutical options for AUD are disulfiram, naltrexone, and acamprosate. Other drugs are being investigated, used off-label (topiramate and ondansetron) or recently approved in Europe (nalmefene) for use in patients with alcohol dependence who want to reduce their alcohol consumption, either as a treatment goal or as a step towards abstinence. While some of these drugs have shown promise in terms of efficacy (nalmefene, topirimate, and ondansetron), none has been found to be effective when used as a single treatment method, without some form of concurrent behavioural therapy. Coexisting diseases (especially mental disorders, but also noncommunicable diseases (NCDs) such as cardiovascular disease, cancer, diabetes or liver disorders) are highly prevalent among people suffering from AUD.8,9 The most recent evidence supports a change from the current practice of treating both diseases (mental disorders and alcohol dependence) separately, to a new approach of incentivizing better coordination between clinics and centres to treat addictions.10 However, effective scaling up of services with improved coordination between health care for AUD and other NCDs has been challenging. In the United States, there are no therapies for ALD which have been approved by the U.S. Food and Drug Administration (FDA). Although many treatment methods have been tried in patients with alcoholic hepatitis, few of them have been consistently shown to have a beneficial effect11 and none has achieved consensus status among practising hepatologists. As a result current therapy still focuses predominantly on supportive care. Research needs Although an increase in funding related to alcohol and health has been reported over the last year in the EU, the level of funding seems insufficient in view of the enormous economic and social burden of ALD on the health care system. More evidence is needed to determine the effectiveness of many of the interventions to reduce harmful alcohol consumption. In addition, health system research is needed to identify appropriate organizational models to effectively coordinate treatment for AUD and other NCDs and to scale these up. With respect to pharmacotherapy, the development of suitable medications with greater selectivity toward excessive alcohol intake remains a major research goal. Efforts to understand the neurobiological basis and their corresponding effects of the pharmacotherapeutic interventions in individuals with AUD, potentially through the use of new imaging technologies, provides relevant avenues for future research. Current treatments for alcohol-related cirrhosis of the liver are severely limited. Better understanding is needed in relation to: the pathogenesis of the disease; helping patients to abstain from alcohol (where possible); eradicating existing viruses using interferon, ribavirin, and lamivudine (in cases involving viral hepatitis); liver 2 6. Priority diseases and reasons for inclusion transplantation;12 and developing adjunctive pharmacotherapies that can improve survival rates.12 References 1 World Health Organization. Alcohol. Management of substance abuse. Available at: http://www.who.int/substance_abuse/facts/alcohol/en/index.html 2 WHO Global Information System on Alcohol and Health (GISAH): Harms and consequences. Geneva: WHO, 2011. Available at: http://www.who.int/gho/alcohol/harms_consequences/en/index.html 3 Alcohol in the European Union. Consumption, harm and policy approaches. Geneva, World Health Organization. Available at: http://www.euro.who.int/__data/assets/pdf_file/0003/160680/ e96457.pdf Last accessed 31 October 2012. 4 Rehm J, Gmel G, Sempos C, Trevisan M. Alcohol Related Morbidity and Mortality [Internet]. National Institute on Alcohol Abuse and Alcoholism. 2012. Available at: http://pubs.niaaa.nih.gov.ezproxy.bu.edu/publications/arh27-1/39-51.htm 5 World Health Organization. Age-standardized death rates of liver cirrhosis. Global Health Observatory. Available at: http://www.who.int/gho/alcohol/harms_consequences/deaths_liver_cirrhosis/en/index.html 6 Savolainen V., Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. Alcohol. Clin. Exp. Res, 1993; 17(5):1112-7. 7 Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. Bull World Health Organ, 2004, 82(11):858-866. 8 Anthenelli RM. Focus on: Comorbid mental health disorders. Alcohol Health & Research World, 2010, 33(1):109. 9 Jane-Llopis. E, Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug and Alcohol Review, 2006, 25(6):515-36. 10 Drake RE, O’Neal EL, Wallach MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat, 2008, 34(1):123-38. 11 Akriviadis E et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology, 2000, 119(6):1637-48. 12 Schuppan D, Afdhal NH. Liver cirrhosis. The Lancet, 2008, 371(9615):838-51. 3 .
Load more

Recommended publications
  • Global Status Report on Alcohol and Health 2018 Global Status Report on Alcohol and Health 2018 ISBN 978-92-4-156563-9
    GLOBAL STATUS REPORT ON ALCOHOL AND HEALTH REPORT GLOBAL STATUS Global status report on alcohol and health 2018 Global status report on alcohol and health 2018 Global status report on alcohol and health 2018 ISBN 978-92-4-156563-9 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC- SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specic organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris.
    [Show full text]
  • Current Trends and Indicators of Alcohol Problems in California
    If you have issues viewing or accessing this file contact us at NCJRS.gov. CURRENT TRENDS AND INDICATORS OF ALCOHOL PROBLEMS IN CALIFORNIA DEPARTMENT OF ALCOHOL AND DRUG PROGRAMS DIVISION OF ADMINISTRATION DATA MANAGEMENT SERVICES BRANCH STATISTICS AND ANALYTICAL STUDIES SECTION & dmscc82:1aura.dms:081189:1g/aa INDICATORS OF ALCOHOL PROBLEMS DEPARTMENT OF ALCOHOL AND DRUG PROGRAMS DIVISION OF ADMINISTRATION DATA MANAGEMENT SERVICES BRANCH STATISTICS AND ANALYTICAL STUDIES SECTION 120265 U.S. Department of Justice National Institute of Justice This document has been reproduced exactly as received from the person or organization originating it. Points of view or opinions stated in this document are those of the authors and do not necessarily represent the official pOSition or policies of the National Institute of Justice. Permission to reproduce this copyrighted material has been granted by California Dept. of Alcohol and Drug Programs to the National Criminal Justice Reference Service (NCJRS). Further reproduction outside of the NCJRS system requires permis­ sion of the copyright owner. FOREWORD As the use of alcohol and the problems related to alcohol abuse increase in our society, so does public concern. The socioeconomic costs (crime, treatment lost employment, reduced productivity, social programs) confronting California's citizens as a result of the problems related to alcohol abuse is conservatively estimated at more than $11 billion annually. This is a cost of over $400 for every man, woman, and child in California. As a result, citizen and parent groups, youth and student organizations, civic groups, law enforcement agencies, educators, health care providers, business leaders, and the community at large are joining together to battle this problem and its consequences to our citizens, especially our youth.
    [Show full text]
  • Alcohol and Health
    TABLE OF CONTENTS Alcohol and Health: Current Evidence ALCOHOL AND HEALTH MARCH-APRIL 2005 OUTCOMES Does Alcohol Consumption Increase the Risk of Ischemic ALCOHOL AND HEALTH OUTCOMES Stroke?, 1 Alcohol May Increase Oral Mu- Does Alcohol Consumption Increase the Risk of Ischemic Stroke? cosal Transmission of HIV, 1 Prior studies of the association between alco- beverage types did not significantly Alcohol Intake, Survival, and hol consumption and ischemic stroke have affect risk. Quality of Life, 2 produced inconsistent results and have limita- • The risk of ischemic stroke was low- tions. To address these issues, researchers est, though not statistically significant, Does Alcohol Consumption assessed alcohol intake and prevalence of inci- in people who consumed 1–2 drinks Decrease the Risk of Coronary dent ischemic stroke (412 cases identified) in on 3–4 days each week (RR 0.7 com- Artery Calcification?, 2 38,156 male health professionals, aged 40–75 pared with those who abstained). years, over a 14-year period. Comments: Although this study reported • In analyses adjusted for potential con- some benefit from red wine use, its clearest founders, the risk of ischemic stroke finding was the increase in risk of ischemic INTERVENTIONS among drinkers versus that of nondrinkers stroke with increasing alcohol consumption, increased as alcohol consumption in- starting at 1–2 drinks per day. The com- Disulfiram or Naltrexone for creased (relative risk [RR] 1.0 for <1 drink plexities associated with beverage type and Alcohol Dependence?, 3 per day, RR 1.3 for 1–2 drinks per day, pattern of use, as indicated in these findings, and RR 1.4 for >2 drinks per day, P=0.01 highlight the challenge in making recom- Talking About Alcohol in Pri- for trend).
    [Show full text]
  • Sanctions for Drunk Driving Accidents Resulting in Serious Injuries And/Or Death
    Sanctions for Drunk Driving Accidents Resulting in Serious Injuries and/or Death State Statutory Citation Description of Penalty Alabama Ala. Code §§ 13A-6-20 & Serious Bodily Injury: Driving under the influence that result in the 13A-5-6(a)(2) serious bodily injury of another person is assault in the first degree, Ala. Code § 13A-6-4 which is a Class B felony. These felonies are punishable by no more than 20 years and no less than two years incarceration. Criminally Negligent Homicide: A person commits the crime of criminally negligent homicide by causing the death of another through criminally negligent conduct. If the death is caused while operating a motor vehicle while under the influence, the punishment is increased to a Class C felony, which is punishable by a prison term of no more than 10 years or less than 1 year and one day. Alaska Alaska Stat. §§ Homicide by Vehicle: Vehicular homicide can be second degree 11.41.110(a)(2), murder, manslaughter, or criminally negligent homicide, depending 11.41.120(a), & on the facts surrounding the death (see Puzewicz v. State, 856 P.2d 11.41.130(a) 1178, 1181 (Alaska App. 1993). Alaska Stat. Ann. § Second degree murder is an unclassified felony and shall be 12.55.125 (West) imprisoned for not less than 15 years nor more than 99 years Manslaughter is a class A felony and punishable by a sentence of not more than 20 years in prison. Criminally Negligent Homicide is a class B felony and punishable by a term of imprisonment of not more than 10 years.
    [Show full text]
  • Prevention of Alcohol Abuse and Illicit Drug Use Annual Awareness and Prevention Program Notice to System Offices Employees
    Prevention of Alcohol Abuse and Illicit Drug Use Annual Awareness and Prevention Program Notice to System Offices Employees Alcohol abuse and illicit drug use disrupt the work and learning environment and create an unsafe and unhealthy workplace. To protect its employees and students and fully serve the citizens of Texas, The Texas A&M University System prohibits alcohol abuse and illicit drug use. This brochure, which is distributed annually, serves as an awareness and prevention tool for System Offices employees by providing basic information about A&M System policy and regulations, legal sanctions and health risks related to alcohol abuse and illicit drug use. Information about counseling, treatment and rehabilitation programs is included. As an employee of The Texas A&M University System, motivation. Drug use by a pregnant woman may cause you must abide by state and federal laws on controlled additional health complications in her unborn child. substances, illicit drugs and use of alcohol. In addition, you must comply with A&M System policy, which states: A&M System Sanctions The Texas A&M University System (system) strictly The A&M System’s drug and alcohol abuse policy and prohibits the unlawful manufacture, distribution, regulation are included in the System Orientation course possession or use of illicit drugs or alcohol on reviewed by new employees as part of their orientation. system property, and/or while on official duty and/or The policy and regulation are posted online at as part of any system activities. http://policies.tamus.edu/34-02.pdf and http://policies.tamus.edu/34-02-01.pdf.
    [Show full text]
  • Ending Drunk Driving with a Flash of Light Andrew Sullivan University of Richmond
    University of Richmond UR Scholarship Repository Law Student Publications School of Law 2015 Ending Drunk Driving with a Flash of Light Andrew Sullivan University of Richmond Follow this and additional works at: http://scholarship.richmond.edu/law-student-publications Part of the Food and Drug Law Commons, and the Transportation Law Commons Recommended Citation Andrew Sullivan, Ending Drunk Driving with a Flash of Light, 21 Rich. J.L. & Tech. 15 (2015). This Article is brought to you for free and open access by the School of Law at UR Scholarship Repository. It has been accepted for inclusion in Law Student Publications by an authorized administrator of UR Scholarship Repository. For more information, please contact [email protected]. Richmond Journal of Law & Technology Volume XXI, Issue 4 ENDING DRUNK DRIVING WITH A FLASH OF LIGHT Andrew Sullivan* Cite as: Andrew Sullivan, Ending Drunk Driving with a Flash of Light, 21 RICH. J.L. & TECH. 15 (2015), http://jolt.richmond.edu/v21i3/article15.pdf. I. INTRODUCTION [1] Drunk driving exacts an enormous toll on our society. Every year, alcohol-driven1 crashes kill over ten thousand people, injure hundreds of thousands more, and cost the national economy tens of billions of dollars.2 States largely have been left to combat this problem through their own criminal regimes. Among the methods used to combat drunk driving is mandating a person convicted of driving under the influence/driving while intoxicated3 install an ignition interlock device (“IID”) in her vehicle as a condition of restoring her driving privileges. Installing an IID prevents a person convicted of a DUI from starting her car if she has a certain amount * J.D.
    [Show full text]
  • 3 Effects of Alcohol Consumption
    Alcohol 2018 Alcohol CONTENTS 1 Overview _________________________________________________________________ 3 2 Prevalence and risks associated with alcohol consumption _________________________ 4 2.1 Alcohol consumption ___________________________________________________________ 4 2.2 Drinking and driving ____________________________________________________________ 6 2.3 The legal limit _______________________________________________________________ 10 2.4 Crashes and injuries ___________________________________________________________ 12 2.5 Characteristics of alcohol-impaired drivers ________________________________________ 18 3 Effects of alcohol consumption ______________________________________________ 19 3.1 Acute impairments due to alcohol consumption _____________________________________ 19 3.2 Chronic impairments due to prolonged alcohol consumption over time __________________ 20 3.3 Effects on driver capabilities ____________________________________________________ 20 4 Measures ________________________________________________________________ 23 4.1 Reducing the availability of alcohol ______________________________________________ 23 4.2 Separating drinking from driving _________________________________________________ 24 4.3 Designated driver programmes __________________________________________________ 27 4.4 Police enforcement ___________________________________________________________ 28 4.5 Education and information _____________________________________________________ 33 4.6 Summary of effective measures _________________________________________________
    [Show full text]
  • Management of Alcohol Use Disorders: a Pocket Reference for Primary Care Providers
    Management of alcohol use disorders: A pocket reference for primary care providers Meldon Kahan, MD Edited by Kate Hardy, MSW and Sarah Clarke, PhD Acknowledgments Mentoring, Education, and Clinical Tools for Addiction: Primary Care–Hospital Integration (META:PHI) is an ongoing initiative to improve the experience of addiction care for both patients and providers. The purpose of this initiative is to set up and implement care pathways for addiction, foster mentoring relationships between addiction physicians and other health care providers, and create and disseminate educational materials for addiction care. This pocket guide is excerpted from Safe prescribing practices for addictive medications and management of substance use disorders in primary care: A pocket reference for primary care providers, a quick-reference tool for primary care providers to assist them in implementing best practices for prescribing potentially addictive medications and managing substance use disorders in primary care, endorsed by the College of Family Physicians of Canada. This excerpt is a guide to talking to patients about their alcohol use and managing at-risk drinking and alcohol use disorders. We thank those who have given feedback on this document: Dr. Mark Ben-Aron, Dr. Peter Butt, Dr. Delmar Donald, Dr. Mike Franklyn, Dr. Melissa Holowaty, Dr. Anita Srivastava, and three anonymous CFPC reviewers. We gratefully acknowledge funding and support from the following organizations: Adopting Research to Improve Care (Health Quality Ontario & Council of Academic Hospitals of Ontario) The College of Family Physicians of Canada Toronto Central Local Health Integration Network Women’s College Hospital Version date: December 19, 2017 © 2017 Women’s College Hospital All rights reserved.
    [Show full text]
  • Alcohol Abuse and Acute Lung Injury and Acute Respiratory Distress
    Journal of Anesthesia & Critical Care: Open Access Review Article Open Access Alcohol abuse and acute lung injury and acute respiratory distress syndrome Introduction Volume 10 Issue 6 - 2018 Alcohol is one of the most commonly used and abused beverage Fadhil Kadhum Zwer Aliqa worldwide. Alcohol is known to have numerous systemic health Private clinic practice, Iraq effects, including on the liver and central nervous system. From a respiratory standpoint, alcohol abuse has long been associated with Correspondence: Fadhil Kadhum Zwer Aliqaby, Private clinic practice, Iraq, Email an increased risk of pneumonia. More recently, alcohol abuse has been strongly linked in epidemiologic studies to development of Received: December 11, 2017 | Published: November 28, ARDS in at-risk patients. The first demonstration of an association 2018 between chronic alcohol abuse and ARDS was made by Moss et al, who retrospectively examined 351 patients at risk for ARDS.1 In this subsequent decreased phagocytosis and bacterial killing. Chronic cohort, 43% of patients who chronically abused alcohol developed alcohol use is similarly associated with altered neutrophil function and ARDS compared to only 22% of those who did not abuse alcohol, decreased superoxide production. Interestingly, chronic alcohol use with the effect most pronounced in patients with sepsis. This study decreases levels of granulocyte/macrophage colony stimulating factor was limited by its retrospective design, particularly since this design (GM-CSF) receptor and signaling in lung epithelium, which has been required that alcohol use history be obtained by chart review and shown to result in defective alveolar macrophage maturation. The documented history; furthermore, this study did not adjust for net effect of these abnormalities is an increased pulmonary bacterial concomitant cigarette smoking.
    [Show full text]
  • Alcohol Withdrawal Syndrome (AWS) in the Acute Care Setting
    Visionary Leadership for Psychiatric-Mental Health Nurses Around the World I N T E R N A T I O N A L S O C I E T Y O F P S Y C H I A T R I C - M E N T A L H E A L T H N U R S E S Position Paper, October 2000 Assessment and Identification Management of Alcohol Withdrawal Syndrome (AWS) in the Acute Care Setting Background Alcoholism is a chronic, neurobiological disorder that leads to a variety of healthcare problems often leading to acute care hospitalization. It is not surprising that alcohol withdrawal syndrome (AWS), is a common occurrence in acute care patients. AWS is a potentially life threatening condition, often coupled with co-morbidities that can adversely affect the outcome of treatment. The focus of this position paper is to address the acute care patient who is at risk for or has developed AWS. Therefore, the recommendations are directed to the patient with alcohol withdrawal. However, many acute care patients are suffering from polysubstance abuse and a strong denial system (patient and family) which often produces either a complex or unexpected withdrawal syndrome presentation. Those patients require immediate referral to addiction or psychiatric nurse/physician specialists in the medical center due to the complex nature of their addiction and possible withdrawal state. The goals of this ISPN position statement are to: promote nursing and medical care that is evidence-based, promote an environment that addresses early identification and aggressive treatment of AWS that is effective and safe, and decrease the use of automatic chemical or mechanical restraints in the treatment of patients with AWS.
    [Show full text]
  • Alcohol and Health
    DRINK AND DRUGS NEWS – WIDER HEALTH SERIES ALCOHOL AND HEALTH e all know that alcohol is linked to health problems; important messages from this supplement is to get people to check in however, the range and scale of those harms is far wider with their GP. However, knowing what some of the symptoms look like, than many of us think. In particular, drinking very heavily and having a sense of what kinds of questions to ask, is invaluable. As with brings with it a number of serious physical risks. This all things, early intervention is essential to preventing potentially tragic Wspecial supplement, which Alcohol Research UK is proud to be sponsoring, consequences down the line. Therefore, the advice contained here will be provides a clear and detailed overview of those risks, as well as advice for of enormous help to anyone working with individuals facing health risks people likely to encounter such problems in their day-to-day work. from their drinking and, of course, to those individuals themselves. As this supplement shows, heavy drinking can cause more than Dr James Nicholls, director of research and policy development, Alcohol liver damage. Its impact on mental health, hypertension, and cancer Research UK risk are only now becoming widely recognised. The revised ‘low risk’ guidelines of 14 units per week for men and women reflect this growing Supported by awareness and are based on a comprehensive analysis of the full range of conditions associated with alcohol consumption. Of course, many people reading this supplement will be dealing with individuals drinking at far higher levels than those set out in the guidelines, and here the risks become very significant.
    [Show full text]
  • Pennsylvania Drug and Alcohol Abuse Control Act."
    § 1690.101. Short title This act shall be known and may be cited as the "Pennsylvania Drug and Alcohol Abuse Control Act." § 1690.102. Definitions (a) The definitions contained and used in the Controlled Substance, Drug, Device and Cosmetic Act shall also apply for the purposes of this act. (b) As used in this act: "CONTROLLED SUBSTANCE" means a drug, substance, or immediate precursor in Schedules I through V of the Controlled Substance, Drug, Device and Cosmetic Act. "COUNCIL" means the Pennsylvania Advisory Council on Drug and Alcohol Abuse established by this act. "COURT" means all courts of the Commonwealth of Pennsylvania, including magistrates and justices of the peace. "DEPARTMENT." The Department of Health. "DRUG" means (i) substances recognized in the official United States Pharmacopeia, or official National Formulary, or any supplement to either of them; and (ii) substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or other animals; and (iii) substances (other than food) intended to affect the structure or any function of the body of man or other animals; and (iv) substances intended for use as a component of any article specified in clause (i), (ii) or (iii), but not including devices or their components, parts or accessories. "DRUG ABUSER" means any person who uses any controlled substance under circumstances that constitute a violation of the law. "DRUG DEPENDENT PERSON" means a person who is using a drug, controlled substance or alcohol, and who is in a state of psychic or physical dependence, or both, arising from administration of that drug, controlled substance or alcohol on a continuing basis.
    [Show full text]